BlueRock Therapeutics
Striving to transform the treatment of disease by harnessing the power of cell therapy
478 employees · est. 2016 · Cambridge, United States
Deyun Kangrui
A pioneering bio-medical enterprise advancing R&D and production in full-chain single-cell multi-omics technology
est. 2020
BlueRock Therapeutics is the older company (2016 vs 2020).
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | BlueRock Therapeutics | Deyun Kangrui |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2020 |
| Headquarters | ||
| Headquarters | Cambridge, United States | Not tracked yet |
| Employees | ||
| Employees | 478 | Not tracked yet |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Manufacturing |
| Funding Stage | ||
| Funding Stage | Acquired | Series A |
| Total Funding | ||
| Total Funding | $1.23B | $220.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 3 |
| Services | ||
| Services | Development of Cell Therapies, Clinical Trial Management, Research and Development | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with Degenerative Diseases, Healthcare Providers, Medical Researchers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cell Therapy, Clinical Stage Biotech, Neurological Diseases, Ophthalmic Diseases, Parkinson’s Disease, Photoreceptor Diseases, Induced Pluripotent Stem Cells (iPSC), Regenerative Medicine, Heart Muscle Regeneration, Myocardial Infarction Treatment, Chronic Heart Failure, Engineered Cell Therapy, Biopharmaceuticals, Stem Cell Therapeutics, Genome Medicine | Biomedical, High-tech Enterprise, R&D, Full-chain Technology, Single-cell Analysis, Multi-omics, Bioinformatics, Precision Medicine |
| Website | ||
| Website | bluerocktx.com | dynamic-biosystems.com |
About BlueRock Therapeutics
BlueRock Therapeutics is a cutting-edge, clinical-stage cell therapy company dedicated to reshaping the landscape of disease treatment. Emphasizing the transformative potential of cell therapy, it has constructed a promising pipeline targeting severe neurological and ophthalmic conditions. Key clini...
About Deyun Kangrui
Deyun Kangrui is a pioneering bio-medical enterprise advancing R&D and production in full-chain single-cell multi-omics technology. Founded in 2020, this bio-medical high-tech enterprise integrates R&D and the production of full-chain single-cell multi-omics technology, operating in the Biotechnolog...
We will tell you when either one moves
BounceWatch watches BlueRock Therapeutics and Deyun Kangrui for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at BlueRock Therapeutics and Deyun Kangrui — by email.
Frequently Asked Questions
Compare BlueRock Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at BlueRock Therapeutics on 9 Jun 2026, and Deyun Kangrui on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
